169 related articles for article (PubMed ID: 3090247)
21. The thyrotropin--releasing hormone (TRH) stimulation of thyrotropin (TSH) and prolactin (PRL) in normal Thai subjects.
Himathongkam T; Namking M; Pavasuthipaisit K; Supasri Y; Pitchayayothin N
J Med Assoc Thai; 1980 Aug; 63(8):454-62. PubMed ID: 6776210
[No Abstract] [Full Text] [Related]
22. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
[TBL] [Abstract][Full Text] [Related]
23. Immediate effects of intermittent administration of domperidone upon prolactin release in normal women.
Ulloa-Aguirre A; del Real O; Méndez JP; Garza-Flores J; Larrea F; Martínez-Campos A
Rev Invest Clin; 1985; 37(4):341-5. PubMed ID: 3938045
[No Abstract] [Full Text] [Related]
24. Prolactin response to buspirone challenge in the presence of dopaminergic blockade.
Maskall DD; Zis AP; Lam RW; Clark CM; Kuan AJ
Biol Psychiatry; 1995 Aug; 38(4):235-9. PubMed ID: 8547445
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of thyrotropin-releasing-hormone stimulation in patients with pituitary tumor.
Cook DM; Greer MA; Paxton H
West J Med; 1987 Aug; 147(2):161-4. PubMed ID: 3116772
[TBL] [Abstract][Full Text] [Related]
26. Dopaminergic modulation of aldosterone secretion in the normal menstrual cycle.
Garcia-Robles R; Ruilope LM; Tovar J; de Pablos P; Parada J; Hurtado A; Miranda B; Fernandez Vazquez G; Rodicio JL; Sancho J
J Clin Hypertens; 1987 Dec; 3(4):470-8. PubMed ID: 3134515
[TBL] [Abstract][Full Text] [Related]
27. Increased prolactin response to thyrotropin-releasing hormone in primary ovarian failure.
Hochner-Celnikier D; Zylber-Haran E; Shilo S; Palti Z; Spitz IM
Obstet Gynecol; 1982 Mar; 59(3):280-4. PubMed ID: 6804899
[TBL] [Abstract][Full Text] [Related]
28. Abnormal prolactin response to thyrotrophic releasing hormone in essential hypertension.
Hauger-Klevene JH; Pinkas MB
Int J Clin Pharmacol Res; 1983; 3(2):111-4. PubMed ID: 6434439
[TBL] [Abstract][Full Text] [Related]
29. Dynamic evaluation of prolactin secretion by successive TRH and metoclopramide stimulations.
Kauppila A; Heikkinen J; Viinikka L
Acta Endocrinol (Copenh); 1986 Jan; 111(1):10-6. PubMed ID: 3080846
[TBL] [Abstract][Full Text] [Related]
30. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
Snyder PJ; Utiger RD
J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
[TBL] [Abstract][Full Text] [Related]
31. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
32. Cholinergic modulation of growth hormone, prolactin and thyroid stimulating hormone responses to thyrotropin-releasing hormone in normal aging.
Giusti M; Giovale M; Sessarego P; Carraro A; Pompei A; Giordano G
Recenti Prog Med; 1995 Sep; 86(9):341-4. PubMed ID: 7569294
[TBL] [Abstract][Full Text] [Related]
33. Effects of body weight on responses of serum prolactin to metoclopramide and thyrotrophin-releasing hormone in secondary amenorrhoeic women.
Takemoto M; Morishita H; Higuchi K; Yoshida J; Aono T
Hum Reprod; 1994 May; 9(5):800-5. PubMed ID: 7929725
[TBL] [Abstract][Full Text] [Related]
34. Investigating the paradox of hypothyroidism and increased serum thyrotropin (TSH) levels in Sheehan's syndrome: characterization of TSH carbohydrate content and bioactivity.
Oliveira JH; Persani L; Beck-Peccoz P; Abucham J
J Clin Endocrinol Metab; 2001 Apr; 86(4):1694-9. PubMed ID: 11297605
[TBL] [Abstract][Full Text] [Related]
35. Effects of erythropoietin administration on prolactin secretion in normal subjects.
Bernini GP; Mariotti F; Brogi G; Cerri F; Santoni M; Ciardella F; Franchi F
Nephron; 1993; 65(4):522-6. PubMed ID: 8302403
[TBL] [Abstract][Full Text] [Related]
36. Prolactin response to exercise, metoclopramide and other provacative agents in children.
Ijaiya K
Eur J Pediatr; 1980 Sep; 134(3):231-7. PubMed ID: 6775949
[TBL] [Abstract][Full Text] [Related]
37. The effects of dopaminergic blockade on serum TSH and prolactin levels in thyrotoxicosis.
Swart S; O'Malley BP; Vora J; Barnett DB; Rosenthal FD
Acta Endocrinol (Copenh); 1984 Jul; 106(3):330-5. PubMed ID: 6429989
[TBL] [Abstract][Full Text] [Related]
38. Effects of thyrotropin-releasing hormone and metoclopramide on PRL secretion in normally cycling and amenorrheic alcoholic women.
Vescovi PP; Coiro V
Drug Alcohol Depend; 1997 Apr; 45(1-2):115-9. PubMed ID: 9179513
[TBL] [Abstract][Full Text] [Related]
39. Oxytocin does not modify the prolactin response to metoclopramide in normal women.
Chiodera P; Volpi R; Gramellini D; Cigarini C; Corradi A; Cavazzini U; Bianconi L; Papadia C; Caiazza A; Capretti L
J Endocrinol Invest; 1991 Jun; 14(6):463-8. PubMed ID: 1774442
[TBL] [Abstract][Full Text] [Related]
40. Painless thyroiditis developed in a patient with Sheehan's syndrome.
Watanobe H; Kawabe H
J Endocrinol Invest; 1997 Jun; 20(6):335-7. PubMed ID: 9294780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
